Literature DB >> 26737522

Improved partial volume correction method for detecting brain activation in disease using Arterial Spin Labeling (ASL) fMRI.

Dylan E Bruening, Shazia Dharssi, Ronald M Lazar, Randolph S Marshall, Iris Asllani.   

Abstract

The insight provided by fMRI, particularly BOLD fMRI, has been critical to the understanding of human brain function. Unfortunately, the application of fMRI techniques in clinical research has been held back by several factors. In order for the clinical field to successfully apply fMRI, two main challenges posed by aging and diseased brains need to be overcome: (1) difficulties in signal measurement and interpretation, and (2) partial voluming effects (PVE). Recent work has addressed the first challenge by developing fMRI methods that, in contrast to BOLD, provide a direct measurement of a physiological correlate of function. One such method is Arterial Spin Labeling (ASL) fMRI, which provides images of cerebral blood flow (CBF) in physiologically meaningful units. Although the problems caused by PVE can be mitigated to some degree through the acquisition of high spatial resolution fMRI data, both hardware and experimental design considerations limit this solution. Our team has developed a PVE correction (PVEc) algorithm that produces CBF images that are theoretically independent of tissue content and the associated PVE. The main drawback of the current PVEc method is that it introduces an inherent smoothing of the functional data. This smoothing effect can reduce the sensitivity of the method, complicating the detection of local changes in CBF, such as those due to stroke or activation. Here, we present results from an improved PVEc algorithm (ssPVEc), which uses high-resolution structural space information to correct for the tissue-driven heterogeneity in the ASL signal. We tested the ssPVEc method on ASL images obtained on patients with asymptomatic carotid occlusive disease during rest and motor activation. Our results showed that the sensitivity of the ssPVEc method (defined as the average T-value in the activated region) was at least 1.5 times greater than that of the original, functional space, fsPVEc, for all patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26737522      PMCID: PMC4791174          DOI: 10.1109/EMBC.2015.7319622

Source DB:  PubMed          Journal:  Annu Int Conf IEEE Eng Med Biol Soc        ISSN: 2375-7477


  5 in total

1.  Regression algorithm correcting for partial volume effects in arterial spin labeling MRI.

Authors:  Iris Asllani; Ajna Borogovac; Truman R Brown
Journal:  Magn Reson Med       Date:  2008-12       Impact factor: 4.668

2.  Partial volume correction of multiple inversion time arterial spin labeling MRI data.

Authors:  M A Chappell; A R Groves; B J MacIntosh; M J Donahue; P Jezzard; M W Woolrich
Journal:  Magn Reson Med       Date:  2011-02-17       Impact factor: 4.668

3.  Separating function from structure in perfusion imaging of the aging brain.

Authors:  Iris Asllani; Christian Habeck; Ajna Borogovac; Truman R Brown; Adam M Brickman; Yaakov Stern
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 4.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia.

Authors:  David C Alsop; John A Detre; Xavier Golay; Matthias Günther; Jeroen Hendrikse; Luis Hernandez-Garcia; Hanzhang Lu; Bradley J MacIntosh; Laura M Parkes; Marion Smits; Matthias J P van Osch; Danny J J Wang; Eric C Wong; Greg Zaharchuk
Journal:  Magn Reson Med       Date:  2014-04-08       Impact factor: 4.668

5.  Arterial Spin Labeling (ASL) fMRI: advantages, theoretical constrains, and experimental challenges in neurosciences.

Authors:  Ajna Borogovac; Iris Asllani
Journal:  Int J Biomed Imaging       Date:  2012-02-22
  5 in total
  1 in total

1.  Motion-corrected and high-resolution anatomically assisted (MOCHA) reconstruction of arterial spin labeling MRI.

Authors:  Abolfazl Mehranian; Colm J McGinnity; Radhouene Neji; Claudia Prieto; Alexander Hammers; Enrico De Vita; Andrew J Reader
Journal:  Magn Reson Med       Date:  2020-03-03       Impact factor: 3.737

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.